0001015325-20-000022.txt : 20200731 0001015325-20-000022.hdr.sgml : 20200731 20200731104815 ACCESSION NUMBER: 0001015325-20-000022 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200731 DATE AS OF CHANGE: 20200731 EFFECTIVENESS DATE: 20200731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Group K Diagnostics, Inc. CENTRAL INDEX KEY: 0001752046 IRS NUMBER: 822570153 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-372205 FILM NUMBER: 201064296 BUSINESS ADDRESS: STREET 1: 3025 MARKET ST., STE. 140 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 201-450-8785 MAIL ADDRESS: STREET 1: 3025 MARKET ST., STE. 140 CITY: PHILADELPHIA STATE: PA ZIP: 19104 D 1 primary_doc.xml X0708 D LIVE 0001752046 Group K Diagnostics, Inc. 1015 Chestnut Street Suite 1010 PHILADELPHIA PA PENNSYLVANIA 19107 201-450-8785 DELAWARE None None Corporation true 2017 Brianna Wronko c/o Group K Diagnostics, Inc. 1015 Chestnut St., Suite 1010 PHILADELPHIA PA PENNSYLVANIA 19107 Executive Officer Director Promoter Paul Farr c/o Group K Diagnostics, Inc. 1015 Chestnut St., Suite 1010 PHILADELPHIA PA PENNSYLVANIA 19107 Director Other Health Care Decline to Disclose 06b false 2020-07-24 false true false 0 1000000 655000 345000 false 4 0 0 43750 true false Group K Diagnostics, Inc. /s/ Brianna Wronko Brianna Wronko Chief Executive Officer 2020-07-30